-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Zura Bio, Lowers Price Target to $5

Benzinga·11/10/2026 16:54:54
Listen to the news
Oppenheimer analyst Jeff Jones maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $16 to $5.